ArticleJournal of clinical medicine2022

Triple-Negative Apocrine Breast Carcinoma Has Better Prognosis despite Poor Response to Neoadjuvant Chemotherapy.

Taobo Hu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.